Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis
Open Access
- 14 April 2015
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 130 (1) , 107-118
Abstract
The Type I interferons (IFN), beta (IFN-β) and the alpha family (IFN-α), act through a common receptor and have anti-inflammatory effects. IFN-β is used to treat multiple sclerosis (MS) and is effective against experimental autoimmune encephalomyelitis (EAE), an animal model for MS. Mice with EAE show elevated levels of Type I IFNs in the central nervous system (CNS), suggesting a role for endogenous Type I IFN during inflammation. However, the therapeutic benefit of Type I IFN produced in the CNS remains to be established. The aim of this study was to examine whether experimentally induced CNS-endogenous Type I IFN influences EAE. Using IFN-β reporter mice, we showed that direct administration of polyinosinic–polycytidylic acid (poly I:C), a potent inducer of IFN-β, into the cerebrospinal fluid induced increased leukocyte numbers and transient upregulation of IFN-β in CD45/CD11b-positive cells located in the meninges and choroid plexus, as well as enhanced IFN-β expression by parenchymal microglial cells. Intrathecal injection of poly I:C to mice showing first symptoms of EAE substantially increased the normal disease-associated expression of IFN-α, IFN-β, interferon regulatory factor-7 and IL-10 in CNS, and disease worsening was prevented for as long as IFN-α/β was expressed. In contrast, there was no therapeutic effect on EAE in poly I:C-treated IFN receptor-deficient mice. IFN-dependent microglial and astrocyte response included production of the chemokine CXCL10. These results show that Type I IFN induced within the CNS can play a protective role in EAE and highlight the role of endogenous type I IFN in mediating neuroprotection.Keywords
This publication has 40 references indexed in Scilit:
- Visualizing Production of Beta Interferon by Astrocytes and Microglia in Brain of La Crosse Virus-Infected MiceJournal of Virology, 2012
- Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in miceJournal of Neuroinflammation, 2011
- Type I IFN Promotes IL-10 Production from T Cells to Suppress Th17 Cells and Th17-Associated Autoimmune InflammationPLOS ONE, 2011
- Toll-like receptor 3, RIG-I-like receptors and the NLRP3 inflammasome: Key modulators of innate immune responses to double-stranded RNA virusesCytokine & Growth Factor Reviews, 2011
- Inflammation in the Central Nervous System and Th17 Responses Are Inhibited by IFN-γ–Induced IL-18 Binding ProteinThe Journal of Immunology, 2010
- Injury-Induced Type I IFN Signaling Regulates Inflammatory Responses in the Central Nervous SystemThe Journal of Immunology, 2010
- Myeloid heme oxygenase–1 regulates innate immunity and autoimmunity by modulating IFN-β productionJournal of Experimental Medicine, 2009
- Visualization of IFNβ production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivoProceedings of the National Academy of Sciences, 2008
- The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in miceJournal of Clinical Investigation, 2008
- Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitisJournal of Leukocyte Biology, 2004